ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
Feature Stories The Women of New York Biotech: 2022 Year in ReviewBy Veta Obazenu, Radhika ShahDecember 30, 2022After a bullish 2021, characterized by a flow of M&A deals and IPOs, this year company valuations were in correction,… Read More
